{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:03:02Z","timestamp":1785542582324,"version":"3.56.0"},"reference-count":19,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T00:00:00Z","timestamp":1221696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We present three cases of children (aged 3\u20135 years) in which cancer\u2010related pain was adequately controlled by Transdermal Buprenorphine. The endpoints for evaluating analgesic efficacy consisted of the assessment of pain using a visual scale and the possibility of reducing other pain treatment. Improvement of pain level was demonstrated by the decrease in pain scores, by reduction of the overall amount of medications, especially opioids, and by improvement of uninterrupted sleep. Only limited data is available on the use of Transdermal Buprenorphine in children. In our experience, Transdermal Buprenorphine allowed good analgesia without significant side effects in these three children with cancer\u2010related pain. Pediatr Blood Cancer 2009;52:125\u2013127. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/pbc.21736","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T21:07:43Z","timestamp":1221772063000},"page":"125-127","source":"Crossref","is-referenced-by-count":17,"title":["Transdermal buprenorphine in children with cancer\u2010related pain"],"prefix":"10.1002","volume":"52","author":[{"given":"Giorgio","family":"Attin\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palma","family":"Maurizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Arlotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Chiaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,18]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1191\/0269216304pm945rr"},{"key":"e_1_2_4_3_2","first-page":"166","volume-title":"Guideline for the management of cancer pain in adults and children","author":"Miaskowski C","year":"2005"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(04)03180-0"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464230-00002"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X53315"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100670200031"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-005-0456-1"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.06.012"},{"key":"e_1_2_4_10_2","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1191\/0269216306pm1125oa","article-title":"Transdermal buprenorphine in cancer pain and palliative care","volume":"20","author":"Sittl R","year":"2006","journal-title":"Palliat Med"},{"key":"e_1_2_4_11_2","first-page":"19","article-title":"Buprenorphine TDS: Use in daily practice, benefits for patients","volume":"133","author":"Radbruch L","year":"2003","journal-title":"Int J Clin Pract Suppl"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.09.002"},{"key":"e_1_2_4_13_2","volume-title":"Buprenorphine transdermal patch: Clinical expert report","author":"Sittl R","year":"2000"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-006-0169-8"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.11.008"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1588"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00294-9"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.02.012"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(90)90018-9"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X89829"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21736","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21736","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.21736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T17:58:22Z","timestamp":1699898302000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.21736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,18]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1002\/pbc.21736"],"URL":"https:\/\/doi.org\/10.1002\/pbc.21736","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,18]]}}}